Some new platinum(II) complexes have been prepared, of general formula trans-[PtCl2(PPh3)NH(Bu)CH2Ar], where the dimension of the Ar residue in the secondary amines has been varied from small phenyl to large pyrenyl group. The obtained complexes, tested in vitro towards a panel of human tumor cell lines showed an interesting antiproliferative effect on both cisplatin-sensitive and -resistant cells. For the most cytotoxic derivative 2a the investigation on the mechanism of action highlighted the ability to induce apoptosis on resistant cells and interestingly, to inhibit the catalytic activity of topoisomerase II
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...
Cisplatin is an efficient anticancer drug, but its effects are often lost after several chemotherapy...
New benzyliminoether derivatives [PtCl(2){N(H)=C(OMe)CH(2)Ph}(2)] of cis (1a, 1b) and trans (2a, 2b)...
Some new platinum(II) complexes have been prepared, of general formula trans-[PtCl2(PPh3)NH(Bu)CH2Ar...
The high incidence of the resistance phenomenon represents one of the most important limitations to ...
Platinum(II) complexes of the type [Pt(Cl)(PPh3){(κ2-N,O)-(1{C(R)=N(OH)-2(O)C6H4})}] with R=Me, H, (...
Platinum(II) complexes of the type [Pt(Cl)(PPh3){(κ2-N,O)-(1{C(R)=N(OH)-2(O)C6H4})}] with R=Me, H, (...
Platinum(II) complexes of the type [Pt(Cl)(PPh3){(κ2-N,O)-(1{C(R)=N(OH)-2(O)C6H4})}] with R=Me, H, (...
Platinum complexes, bearing aliphatic amines and phosphine ligands in trans configuration with iodid...
Ionic platinum(II) complexes [PtCl(PPh3)(L∧L)][BF4] {L∧L = 2,2′-bipyridyl (1) 1,10-phenanthroline (2...
Ionic platinum(II) complexes [PtCl(PPh3)(L∧L)][BF4] {L∧L = 2,2′-bipyridyl (1) 1,10-phenanthroline (2...
Ionic platinum(II) complexes [PtCl(PPh3)(L∧L)][BF4] {L∧L = 2,2′-bipyridyl (1) 1,10-phenanthroline (2...
A series of neutral complexes of platinum(II) of general formula [PtCl2L(PPh3)] [L = Et2NC(Me)NH, SO...
New pyridinimino complexes of platinum(II) [PtCl2(N^N-R)] (N^N = 2-pyridylmethanimino, R = -(CH2)2O(...
Treatment of cis/trans-[PtCl2(N≡CR)2] 1 (R = CH3 (1a), C2H5 (1b), C6H5 (1c), CH2C6H4(p-CH3) (1d)) wi...
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...
Cisplatin is an efficient anticancer drug, but its effects are often lost after several chemotherapy...
New benzyliminoether derivatives [PtCl(2){N(H)=C(OMe)CH(2)Ph}(2)] of cis (1a, 1b) and trans (2a, 2b)...
Some new platinum(II) complexes have been prepared, of general formula trans-[PtCl2(PPh3)NH(Bu)CH2Ar...
The high incidence of the resistance phenomenon represents one of the most important limitations to ...
Platinum(II) complexes of the type [Pt(Cl)(PPh3){(κ2-N,O)-(1{C(R)=N(OH)-2(O)C6H4})}] with R=Me, H, (...
Platinum(II) complexes of the type [Pt(Cl)(PPh3){(κ2-N,O)-(1{C(R)=N(OH)-2(O)C6H4})}] with R=Me, H, (...
Platinum(II) complexes of the type [Pt(Cl)(PPh3){(κ2-N,O)-(1{C(R)=N(OH)-2(O)C6H4})}] with R=Me, H, (...
Platinum complexes, bearing aliphatic amines and phosphine ligands in trans configuration with iodid...
Ionic platinum(II) complexes [PtCl(PPh3)(L∧L)][BF4] {L∧L = 2,2′-bipyridyl (1) 1,10-phenanthroline (2...
Ionic platinum(II) complexes [PtCl(PPh3)(L∧L)][BF4] {L∧L = 2,2′-bipyridyl (1) 1,10-phenanthroline (2...
Ionic platinum(II) complexes [PtCl(PPh3)(L∧L)][BF4] {L∧L = 2,2′-bipyridyl (1) 1,10-phenanthroline (2...
A series of neutral complexes of platinum(II) of general formula [PtCl2L(PPh3)] [L = Et2NC(Me)NH, SO...
New pyridinimino complexes of platinum(II) [PtCl2(N^N-R)] (N^N = 2-pyridylmethanimino, R = -(CH2)2O(...
Treatment of cis/trans-[PtCl2(N≡CR)2] 1 (R = CH3 (1a), C2H5 (1b), C6H5 (1c), CH2C6H4(p-CH3) (1d)) wi...
The antitumor and cellular pharmacological properties of the trans-Pt(IV) complex, trans-[PtCl2(OH)(...
Cisplatin is an efficient anticancer drug, but its effects are often lost after several chemotherapy...
New benzyliminoether derivatives [PtCl(2){N(H)=C(OMe)CH(2)Ph}(2)] of cis (1a, 1b) and trans (2a, 2b)...